Categories
Change Password!
Reset Password!
In this study, the treatment effectiveness of radial extracorporeal shock wave therapy (ESWT) and ultrasound (US)-guided dextrose prolotherapy has been compared in patients with chronic plantar fasciitis (PF).
Prolotherapy has gained popularity in the area of
musculoskeletal medicine but there are limited studies about its efficacy. Both
dextrose prolotherapy injection and radial extracorporeal shock wave therapy
had alike effectiveness in terms of pain and function improvement at 3 months,
this study revealed.
In this study, the treatment effectiveness of
radial extracorporeal shock wave therapy (ESWT) and ultrasound (US)-guided
dextrose prolotherapy has been compared in patients with chronic plantar
fasciitis (PF).
Fifty-nine patients with chronic
PF were assigned into 2 groups receiving 3 sessions of radial ESWT (n = 29)
versus 2 sessions of ultrasound-guided intrafascial 2 cc dextrose 20% injection
(n = 30) at random. Pain intensity by routine life and exercise activities by
Foot and Ankle Ability Measure (FAAM), visual analogue scale (VAS), and the PF
thickness via US imaging were assessed prior to and then at 6 and 12 weeks
after the use of these therapies.
Both groups had substantial improvements in pain and
function at 6 weeks and 12 weeks after the treatments. At these periods, a
significant reduction was noted for PF thickness. Other than the FAAM-sport
subscale which favoured the use of ESWT, no significant results for other
outcomes measures were found. There were no severe adverse effects.
In PF patients, dextrose prolotherapy had comparable
efficacy to radial ESWT in providing pain relief, routine-life functional
limitation, and PF thickness.
Foot and Ankle Surgery
Dextrose prolotherapy versus radial extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: A randomized, controlled clinical trial
Mahsa Asheghan et al.
Comments (0)